Papua New Guinea vs Vanuatu: Statin use vs average non hdl cholesterol levels
Papua New Guinea
3.6
in 2018
Vanuatu
3.6
in 2018
Papua New Guinea rank
30th
Vanuatu rank
30th
Statin use vs average non hdl cholesterol levels over time
- Papua New Guinea
- Vanuatu
How they compare
Papua New Guinea currently reports 3.6 against 3.6 in Vanuatu, a difference of 0.
The two have swapped places 6 times across 39 shared years of data; in 1980 it was Vanuatu ahead.
Papua New Guinea ranks 30th and Vanuatu ranks 30th of 191 countries.
Papua New Guinea has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Papua New Guinea | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.33 | 3.32 | 0.01 | Papua New Guinea |
| 1990s | 3.48 | 3.47 | 0.01 | Papua New Guinea |
| 2000s | 3.54 | 3.52 | 0.02 | Papua New Guinea |
| 2010s | 3.6 | 3.6 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs average non hdl cholesterol levels, Papua New Guinea or Vanuatu?
- Papua New Guinea, at 3.6 against 3.6 in Vanuatu as of 2018.
- What is the difference in statin use vs average non hdl cholesterol levels between Papua New Guinea and Vanuatu?
- 0, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and Vanuatu?
- 39 years are reported by both, from 1980 to 2018.
- How do Papua New Guinea and Vanuatu rank globally for statin use vs average non hdl cholesterol levels?
- Papua New Guinea ranks 30th and Vanuatu ranks 30th of 191 countries.
- Where does this data come from?
- Our World in Data, published as Statin use vs average non hdl cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.